Novo Nordisk A/S News - September 7, 2026

Novo Nordisk Wegovy Cuts Obesity in 40% of Children, Trial Finds

Novo Nordisk reported positive results from its late-stage STEP Young trial for semaglutide in children aged 6 to under 12. Semaglutide serves as the active...

Novo Nordisk Scraps Two Heart Trials, Stalling Expansion Beyond Obesity Drugs

Novo Nordisk has terminated the HERMES and ATHENA late-stage clinical trials for its experimental drug, ziltivekimab. An independent data monitoring committee...